Table 5.
Characteristic | Adjusted Prevalence Ratios (95% CI) |
P- Value |
Previous DR-TB Treatment | ||
No | 1 | |
Yes | 3.46 (1.68 – 7.14) | 0.001 |
Treatment registration group | ||
New (N) | 1 | |
Relapse (Rp) | 0.43 (0.10 – 1.78) | 0.245 |
After loss to follow-up (Rt) | 1.77 (0.76– 4.12) | 0.186 |
After failure of first treatment with first-line drugs (F1) |
0.86 (0.27 – 2.72) | 0.803 |
After failure of retreatment regimen with first line drugs (F2) |
0.44 (0.09 – 2.05) | 0.295 |
After failure of regimen with second-line drugs (F4) and others |
1.85(0.57–6.05) | 0.306 |